Nader Alerasool
Impact in
-
- RNA modifications and cancer
- CRISPR and Genetic Engineering
- RNA and protein synthesis mechanisms
- RNA Research and Splicing
- Epigenetics and DNA Methylation
- Cancer-related gene regulation
- Genomics and Chromatin Dynamics
Papers in
- Aging 1
-
- Genomics and Chromatin Dynamics 4
- Ubiquitin and proteasome pathways 3
- Protein Degradation and Inhibitors 3
- RNA and protein synthesis mechanisms 2
- RNA modifications and cancer 1
- Protein Structure and Dynamics 1
- CRISPR and Genetic Engineering 1
- Co-authors
- Mikko TaipaleDmitri SegalHunsang LeeAnne‐Claude GingrasGiuseppina FedericoFrank LykoZhen‐Yuan LinHermann‐Josef Gröne
- Journals
- Molecular Cell (2 papers)Nature Methods (1 paper)The EMBO Journal (1 paper)Nature (1 paper)Biophysical Journal (1 paper)
- Partner nations
- CanadaUnited StatesGermany
In The Last Decade
Nader Alerasool
8 papers receiving 483 citations
Peers
Comparison fields: 5 of 66
- Aging 17
- Molecular Biology 439
- Cancer Research 72
- Business and International Management 6
- Virology 8
Countries citing papers authored by Nader Alerasool
This map shows the geographic impact of Nader Alerasool's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nader Alerasool with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nader Alerasool more than expected).
Fields of papers citing papers by Nader Alerasool
This network shows the impact of papers produced by Nader Alerasool. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nader Alerasool. The network helps show where Nader Alerasool may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Nader Alerasool, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 29 | |
| 2 | 2022 | 15 | |
| 3 | 2022 | 7 | |
| 4 | 2022 | 66 | |
| 5 | 2022 | 3 | |
| 6 | 2021 | 51 | |
| 7 | 2020 | 152 | |
| 8 | 2015 | 163 |
About Nader Alerasool
Nader Alerasool is a scholar working on Aging, Molecular Biology, Oncology, Materials Chemistry and Infectious Diseases, having authored 8 papers that have together received 486 indexed citations. Recurring topics across this work include Genomics and Chromatin Dynamics (4 papers), Ubiquitin and proteasome pathways (3 papers), Protein Degradation and Inhibitors (3 papers), RNA and protein synthesis mechanisms (2 papers), RNA modifications and cancer (1 paper), Protein Structure and Dynamics (1 paper), CRISPR and Genetic Engineering (1 paper) and Peptidase Inhibition and Analysis (1 paper). The work is most often cited by research in Aging (17 citations), Molecular Biology (439 citations), Cancer Research (72 citations), Business and International Management (6 citations) and Virology (8 citations). Nader Alerasool has collaborated with scholars based in Canada, United States and Germany. Frequent co-authors include Mikko Taipale, Dmitri Segal, Hunsang Lee, Anne‐Claude Gingras, Giuseppina Federico, Frank Lyko, Zhen‐Yuan Lin, Hermann‐Josef Gröne, Hanno Glimm and Oliver Popp. Their work appears in journals such as Molecular Cell, Nature Methods, The EMBO Journal, Nature and Biophysical Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.